Adiposopathy is "sick fat" a cardiovascular disease?

[1]  C. Torp‐Pedersen,et al.  Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. , 2011, Journal of the American College of Cardiology.

[2]  S. Anker,et al.  Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity‐matched study , 2011, European journal of heart failure.

[3]  O. Ozeke,et al.  Chronic intermittent hypoxia caused by obstructive sleep apnea may play an important role in explaining the morbidity-mortality paradox of obesity. , 2011, Medical hypotheses.

[4]  H. Bays,et al.  What men should know about metabolic syndrome, adiposopathy and ‘sick fat’ , 2010, International journal of clinical practice.

[5]  C. Langefeld,et al.  Ethnic differences in the relationship between pericardial adipose tissue and coronary artery calcified plaque: African-American-diabetes heart study. , 2010, The Journal of clinical endocrinology and metabolism.

[6]  Z. Bloomgarden.  World Congress on the Insulin Resistance Syndrome, 2009 , 2010, Diabetes Care.

[7]  M. Jensen,et al.  Sex‐ and Depot‐Dependent Differences in Adipogenesis in Normal‐Weight Humans , 2010, Obesity.

[8]  F. Hou,et al.  Advanced Oxidation Protein Products Induce Inflammatory Response and Insulin Resistance in Cultured Adipocytes via Induction of Endoplasmic Reticulum Stress , 2010, Cellular Physiology and Biochemistry.

[9]  M. Berneburg.  Research in practice: More than skin deep –aging of subcutaneous fat tissue , 2010, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[10]  T. Jones,et al.  Fatness, fitness, and increased cardiovascular risk in young children. , 2010, The Journal of pediatrics.

[11]  K. Fox,et al.  Anthropometric measurements and diabetes mellitus: clues to the "pathogenic" and "protective" potential of adipose tissue. , 2010, Metabolic syndrome and related disorders.

[12]  C. Fox,et al.  Pericardial Adipose Tissue, Atherosclerosis, and Cardiovascular Disease Risk Factors: The Jackson Heart Study , 2010, Diabetes Care.

[13]  J. Hardies,et al.  Pioglitazone in the treatment of NASH: the role of adiponectin , 2010, Alimentary pharmacology & therapeutics.

[14]  A. Terzic,et al.  Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. , 2010, Journal of the American College of Cardiology.

[15]  H. Bays.  Phentermine, topiramate and their combination for the treatment of adiposopathy (‘sick fat’) and metabolic disease , 2010, Expert review of cardiovascular therapy.

[16]  F. Tinahones,et al.  The obese healthy paradox: is inflammation the answer? , 2010, The Biochemical journal.

[17]  B. S. Mohammed,et al.  Increased Whole‐Body Adiposity Without a Concomitant Increase in Liver Fat is Not Associated With Augmented Metabolic Dysfunction , 2010, Obesity.

[18]  Ke Chen,et al.  Multiple Symmetric Lipomatosis: Substantial Subcutaneous Adipose Tissue Accumulation Did Not Induce Glucose and Lipid Metabolism Dysfunction , 2010, Annals of Nutrition and Metabolism.

[19]  F. Crea,et al.  Paradoxical preservation of vascular function in severe obesity. , 2010, The American journal of medicine.

[20]  R. Eckel,et al.  Inflexibility in Intramuscular Triglyceride Fractional Synthesis Distinguishes Prediabetes From Obesity in Humans , 2010, Obesity.

[21]  N. Weissman,et al.  Multicenter, placebo-controlled trial of lorcaserin for weight management. , 2010, The New England journal of medicine.

[22]  A. Salminen,et al.  ER stress and hormetic regulation of the aging process , 2010, Ageing Research Reviews.

[23]  M. Allende-Vigo.  Pathophysiologic mechanisms linking adipose tissue and cardiometabolic risk. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[24]  C. Lavie,et al.  Body composition and heart failure prevalence and prognosis: getting to the fat of the matter in the "obesity paradox". , 2010, Mayo Clinic proceedings.

[25]  L. Afonso,et al.  Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. , 2010, The American journal of medicine.

[26]  J. Morley,et al.  Late-life onset hypogonadism: a review. , 2010, Clinics in geriatric medicine.

[27]  R. DeFronzo.  Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009 , 2010, Diabetologia.

[28]  F. Villarroya,et al.  Drug-induced lipotoxicity: lipodystrophy associated with HIV-1 infection and antiretroviral treatment. , 2010, Biochimica et biophysica acta.

[29]  J. Myers,et al.  Obesity paradox and cardiorespiratory fitness in 12,417 male veterans aged 40 to 70 years. , 2010, Mayo Clinic proceedings.

[30]  P. Savage,et al.  The obesity paradox: perception vs knowledge. , 2010, Mayo Clinic proceedings.

[31]  R. de Caterina,et al.  Adipose tissue: a new source for cardiovascular repair , 2010, Journal of cardiovascular medicine.

[32]  E. Mariman,et al.  Adipocyte extracellular matrix composition, dynamics and role in obesity , 2010, Cellular and Molecular Life Sciences.

[33]  D. Feeny,et al.  BMI and Mortality: Results From a National Longitudinal Study of Canadian Adults , 2010, Obesity.

[34]  H. Katus,et al.  The obesity paradox in stable chronic heart failure does not persist after matching for indicators of disease severity and confounders , 2009, European journal of heart failure.

[35]  C. Lavie,et al.  The obesity paradox, weight loss, and coronary disease. , 2009, The American journal of medicine.

[36]  D. Houston,et al.  Weighty concerns: the growing prevalence of obesity among older adults. , 2009, Journal of the American Dietetic Association.

[37]  H. Bays.  Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for ‘sick fat’ and metabolic disease , 2009, Expert review of cardiovascular therapy.

[38]  P. Scherer,et al.  Mechanisms of obesity and related pathologies: The macro‐ and microcirculation of adipose tissue , 2009, The FEBS journal.

[39]  K. Yoshimura,et al.  Characterization of Structure and Cellular Components of Aspirated and Excised Adipose Tissue , 2009, Plastic and reconstructive surgery.

[40]  Adiposopathy and bariatric surgery: is ‘sick fat’ a surgical disease? , 2009, International journal of clinical practice.

[41]  M. Joglekar,et al.  Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. , 2009, Cytotherapy.

[42]  K. Atkinson,et al.  Molecular Mechanisms Involved in Mesenchymal Stem Cell Migration to the Site of Acute Myocardial Infarction , 2009, International journal of cell biology.

[43]  D. Allison,et al.  Mortality, Health Outcomes, and Body Mass Index in the Overweight Range: A Science Advisory From the American Heart Association , 2009, Circulation.

[44]  C. Lavie,et al.  Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. , 2009, Journal of the American College of Cardiology.

[45]  M. Blüher,et al.  Adipose tissue dysfunction in obesity. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[46]  G. Bray,et al.  Lower Total Adipocyte Number but No Evidence for Small Adipocyte Depletion in Patients With Type 2 Diabetes , 2009, Diabetes Care.

[47]  Hui Wang,et al.  Role of oxidative stress in elevated blood pressure induced by high free fatty acids , 2009, Hypertension Research.

[48]  F. Andreotti,et al.  Body fat and cardiovascular risk: understanding the obesity paradox. , 2008, European heart journal.

[49]  H. Bays.  "Sick fat," metabolic disease, and atherosclerosis. , 2009, The American journal of medicine.

[50]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[51]  J. Ye.  Emerging role of adipose tissue hypoxia in obesity and insulin resistance , 2009, International Journal of Obesity.

[52]  D. Reeds,et al.  Long‐term Effects of Large‐volume Liposuction on Metabolic Risk Factors for Coronary Heart Disease , 2008, Obesity.

[53]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[54]  C. Lavie,et al.  The "obesity paradox": is smoking/lung disease the explanation? , 2008, Chest.

[55]  H. Rodbard,et al.  Is adiposopathy (sick fat) an endocrine disease? , 2008, International journal of clinical practice.

[56]  Raj Padwal,et al.  Body mass index and mortality in heart failure: a meta-analysis. , 2008, American heart journal.

[57]  Tom Britton,et al.  Dynamics of fat cell turnover in humans , 2008, Nature.

[58]  D. Mozaffarian,et al.  The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. , 2008, Clinical chemistry.

[59]  G. Bray,et al.  Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity , 2008, Expert review of cardiovascular therapy.

[60]  S. Grundy,et al.  The influence of age and body mass index on the metabolic syndrome and its components , 2008, Diabetes, obesity & metabolism.

[61]  C. Lavie,et al.  The Obesity Paradox: Impact of Obesity on the Prevalence and Prognosis of Cardiovascular Diseases , 2008, Postgraduate medicine.

[62]  Bohan Wang,et al.  Hypoxia and the endocrine and signalling role of white adipose tissue. , 2008, Archives of physiology and biochemistry.

[63]  M. Jensen,et al.  Subcutaneous adipocyte size and body fat distribution. , 2008, The American journal of clinical nutrition.

[64]  U. Smith.  VISCERAL FAT, LIKE EPICARDIAL FAT, IS AN ECTOPIC FAT DEPOT WHICH REFLECTS CARDIOMETABOLIC RISK IN OBESITY , 2008 .

[65]  K. Clément,et al.  Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity , 2008, Genome Biology.

[66]  J. Baatz,et al.  Succination of Protein Thiols during Adipocyte Maturation , 2007, Journal of Biological Chemistry.

[67]  Jianping Ye,et al.  Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. , 2007, American journal of physiology. Endocrinology and metabolism.

[68]  A. Lincoff,et al.  Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. , 2007, JAMA.

[69]  Shuiping Zhao,et al.  Effects of Atorvastatin on C-reactive Protein Secretions by Adipocytes in Hypercholesterolemic Rabbits , 2007, Journal of cardiovascular pharmacology.

[70]  H. Rodbard,et al.  Adiposopathy: Treating pathogenic adipose tissue to reduce cardiovascular disease risk , 2007, Current treatment options in cardiovascular medicine.

[71]  A. Sherman,et al.  Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis , 2007, Diabetologia.

[72]  R. Bhopal,et al.  Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. , 2007, International journal of epidemiology.

[73]  D. Lawlor,et al.  Reverse Causality and Confounding and the Associations of Overweight and Obesity with Mortality , 2006, Obesity.

[74]  L. Blonde,et al.  Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients? , 2006, Expert review of cardiovascular therapy.

[75]  O. Hamdy,et al.  Metabolic obesity: the paradox between visceral and subcutaneous fat. , 2006, Current diabetes reviews.

[76]  M. Davidson.  Does the Metabolic Syndrome Exist , 2006, Diabetes Care.

[77]  E. Ravussin,et al.  Decreased Expression of Adipogenic Genes in Obese Subjects with Type 2 Diabetes , 2006, Obesity.

[78]  V. Montori,et al.  Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies , 2006, The Lancet.

[79]  Christie M. Ballantyne,et al.  Adiposopathy: why do adiposity and obesity cause metabolic disease? , 2006 .

[80]  R. Niaura,et al.  A Single Factor Underlies the Metabolic Syndrome: A Confirmatory Factor Analysis , 2006, Diabetes Care.

[81]  D. Chan.  Mitochondria: Dynamic Organelles in Disease, Aging, and Development , 2006, Cell.

[82]  G. Reaven,et al.  The metabolic syndrome: is this diagnosis necessary? , 2006, The American journal of clinical nutrition.

[83]  U. Müller-Ladner,et al.  Role of adipose tissue as an inflammatory organ in human diseases. , 2006, Endocrine reviews.

[84]  K. Cianflone,et al.  Leptin and adiponectin in relation to body fat percentage, waist to hip ratio and the apoB/apoA1 ratio in Asian Indian and Caucasian men and women , 2006, Nutrition & metabolism.

[85]  H. Bays,et al.  Adiposopathy is a more rational treatment target for metabolic disease than obesity alone , 2006, Current atherosclerosis reports.

[86]  Paul Poirier,et al.  Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism , 2006, Circulation.

[87]  M. Jensen.  Is Visceral Fat Involved in the Pathogenesis of the Metabolic Syndrome? Human Model , 2006, Obesity.

[88]  R. Bonser,et al.  Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease , 2006, Cardiovascular diabetology.

[89]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[90]  J. Leahy.  The Metabolic Syndrome: Time for a Critical Appraisal: Joint Statement From the American Diabetes Association and the European Association for the Study of Diabetes , 2006 .

[91]  A. Sniderman,et al.  The adipocyte life cycle hypothesis. , 2006, Clinical science.

[92]  N. Abate,et al.  Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia. , 2005, Future cardiology.

[93]  S. Engeli.  Is there a pathophysiological role for perivascular adipocytes? , 2005, American journal of physiology. Heart and circulatory physiology.

[94]  E Jørgensen,et al.  Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention , 2005, Heart.

[95]  P Trayhurn,et al.  Signalling role of adipose tissue: adipokines and inflammation in obesity. , 2005, Biochemical Society transactions.

[96]  E. Yeh.  A new perspective on the biology of C-reactive protein. , 2005, Circulation research.

[97]  Richard Kahn,et al.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.

[98]  J. B. Kim,et al.  Hypoxia inhibits adipocyte differentiation in a HDAC-independent manner. , 2005, Biochemical and biophysical research communications.

[99]  A. Galinier,et al.  Adipose tissues as an ancestral immune organ: Site‐specific change in obesity , 2005, FEBS letters.

[100]  A. Lumsden,et al.  Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. , 2005, The Journal of surgical research.

[101]  H. Ginsberg,et al.  Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. , 2005, Circulation research.

[102]  H. Bays.  Adiposopathy, metabolic syndrome, quantum physics, general relativity, chaos and the Theory of Everything , 2005, Expert review of cardiovascular therapy.

[103]  S. Grinspoon,et al.  Racial differences in fat distribution: the importance of intermuscular fat. , 2005, The American journal of clinical nutrition.

[104]  Morihiro Matsuda,et al.  Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.

[105]  E. Ravussin,et al.  Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus , 2004, International Journal of Obesity.

[106]  S. Haffner,et al.  Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? , 2004, Diabetes care.

[107]  G. Reaven,et al.  The metabolic syndrome: one step forward, two steps back , 2004, Diabetes & vascular disease research.

[108]  H. Bays.  Current and investigational antiobesity agents and obesity therapeutic treatment targets. , 2004, Obesity research.

[109]  S. Klein,et al.  The case of visceral fat: argument for the defense. , 2004, The Journal of clinical investigation.

[110]  Remi Rabasa-Lhoret,et al.  Metabolic and body composition factors in subgroups of obesity: what do we know? , 2004, The Journal of clinical endocrinology and metabolism.

[111]  S. Grundy,et al.  Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men. , 2004, The Journal of clinical endocrinology and metabolism.

[112]  Lan Li,et al.  C-Reactive Protein Accelerates the Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice , 2004, Circulation.

[113]  R. DeFronzo,et al.  Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. , 2004, The Journal of clinical endocrinology and metabolism.

[114]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[115]  B. Goldstein,et al.  Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators , 2003, Circulation.

[116]  Shuiping Zhao,et al.  Atorvastatin reduces interleukin-6 plasma concentration and adipocyte secretion of hypercholesterolemic rabbits. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[117]  Eric J Topol,et al.  Prevalence of conventional risk factors in patients with coronary heart disease. , 2003, JAMA.

[118]  E. Edelman,et al.  Increased Thrombosis After Arterial Injury in Human C-Reactive Protein–Transgenic Mice , 2003, Circulation.

[119]  M. Mccarty,et al.  A paradox resolved: the postprandial model of insulin resistance explains why gynoid adiposity appears to be protective. , 2003, Medical hypotheses.

[120]  S. Grundy,et al.  Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States. , 2003, The Journal of clinical endocrinology and metabolism.

[121]  J. Critchley,et al.  Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. , 2003, JAMA.

[122]  C. Lavie,et al.  Body composition and prognosis in chronic systolic heart failure: the obesity paradox. , 2002, The American journal of cardiology.

[123]  Steven R Smith,et al.  Human mesenchymal stem cells as an in vitro model for human adipogenesis. , 2003, Obesity research.

[124]  Min Zhu,et al.  Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.

[125]  P. Libby,et al.  Comparison between adventitial and intimal inflammation of ruptured and nonruptured atherosclerotic plaques in human coronary arteries. , 2002, Arquivos brasileiros de cardiologia.

[126]  J. Kirkland,et al.  Adipogenesis and aging: does aging make fat go MAD? , 2002, Experimental Gerontology.

[127]  E. Ravussin,et al.  Increased Fat Intake, Impaired Fat Oxidation, and Failure of Fat Cell Proliferation Result in Ectopic Fat Storage, Insulin Resistance, and Type 2 Diabetes Mellitus , 2002, Annals of the New York Academy of Sciences.

[128]  S. Goodwin,et al.  The Practical Guide to the Identification, Evaluation and Treatment of Overweight and Obesity in Adults , 2002 .

[129]  F. Lönnqvist,et al.  A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding , 2002, International Journal of Obesity.

[130]  B. Howard,et al.  Diabetes and cardiovascular disease , 2000, Annual review of medicine.

[131]  I. Kushner.  C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biologic aging. , 2001, Cleveland Clinic journal of medicine.

[132]  D. Barbier.  [Depression in the elderly. Clinical aspects]. , 2001, Presse medicale.

[133]  D. Cox,et al.  Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance. , 2001, Journal of molecular medicine.

[134]  F. Pi-Sunyer,et al.  Impaired insulin action in subcutaneous adipocytes from women with visceral obesity. , 2001, American journal of physiology. Endocrinology and metabolism.

[135]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[136]  C. Bogardus,et al.  Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts Type II diabetes independent of insulin resistance , 2000, Diabetologia.

[137]  E. Danforth.  Failure of adipocyte differentiation causes type II diabetes mellitus? , 2000, Nature Genetics.

[138]  G. Shulman,et al.  Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. , 2000, The Journal of clinical investigation.

[139]  S. Grundy,et al.  Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. , 1999, The Journal of clinical endocrinology and metabolism.

[140]  J. Sowers,et al.  Diabetes and cardiovascular disease. , 1999, Diabetes care.

[141]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[142]  B. Goodpaster,et al.  Subcutaneous Abdominal Fat and Thigh Muscle Composition Predict Insulin Sensitivity Independently of Visceral Fat , 1997, Diabetes.

[143]  E. Stadtman,et al.  Protein Oxidation in Aging, Disease, and Oxidative Stress* , 1997, The Journal of Biological Chemistry.

[144]  M. Jensen,et al.  Contribution of leg and splanchnic free fatty acid (FFA) kinetics to postabsorptive FFA flux in men and women. , 1996, Metabolism: clinical and experimental.

[145]  M. Stern.  Diabetes and Cardiovascular Disease: The “Common Soil” Hypothesis , 1995, Diabetes.

[146]  G. Reaven.  Syndrome X: 6 years later. , 1994, Journal of internal medicine. Supplement.

[147]  Y. Goto.  [Lipid metabolism in the elderly]. , 1988, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[148]  K. Anderson,et al.  A population at risk: Prevalence of high cholesterol levels in hypertensive patients in the framingham study , 1986 .

[149]  M. Hochberg,et al.  Primary Sjögren's syndrome in men. Clinical, serologic, and immunogenetic features. , 1986, The American journal of medicine.

[150]  M. Hanefeld,et al.  Basal and stimulated hyperinsulinemia in obesity: relationship to adipose-cell size. , 1979, Endokrinologie.

[151]  E. A. Sims,et al.  Glucose metabolism and the response to insulin by human adipose tissue in spontaneous and experimental obesity. Effects of dietary composition and adipose cell size. , 1974, The Journal of clinical investigation.

[152]  M. Hanefeld,et al.  [Relation of blood pressure to the body weight index and to metabolic parameters]. , 1973, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete.

[153]  A. Tiengo,et al.  [Metabolic aspects of essential obesity]. , 1965, Epatologia.